V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270015885 | 270008093 | null | null | Curative (C) | 2018-06-10 | 2018-06-10 | Capecitabine | 02 | null | 270011771 | CAPECITABINE |
| 270015886 | 270008094 | 1.66 | 46 | Curative (C) | 2016-01-12 | 2016-07-05 | Capecitabine | 02 | N | 270011778 | CAPECITABINE |
| 270015887 | 270008095 | 1.5 | 63.2 | Disease modification (D) | 2018-01-31 | 2018-01-31 | Brentuximab | N | N | 270011780 | BRENTUXIMAB |
| 270015888 | 270013841 | 1.86 | 69 | Palliative (P) | 2016-03-18 | 2016-03-28 | CAPECITABINE + OXALIPLATIN | 02 | N | 270011791 | CAPECITABINE + OXALIPLATIN |
| 270015889 | 270008099 | 1.73 | 137.6 | null | 2018-11-28 | 2018-12-12 | Brentuximab | N | null | 270011793 | BRENTUXIMAB |
| 270015890 | 270013844 | null | 60.2 | Curative (C) | 2016-12-28 | 2017-01-14 | Brentuximab | 2 | N | 270011807 | BRENTUXIMAB |
| 270015891 | 270008106 | 1.73 | null | null | 2016-10-02 | 2016-10-26 | Brentuximab | N | N | 270011813 | BRENTUXIMAB |
| 270015892 | 270008108 | 1.76 | 96.8 | Curative (C) | 2016-03-18 | 2016-03-19 | Capecitabine | N | N | 270011818 | CAPECITABINE |
| 270015893 | 270008108 | 1.72 | 47.5 | Palliative (P) | 2017-07-18 | 2017-07-21 | Capecitabine + Oxaliplatin 21day | 02 | N | 270011818 | CAPECITABINE + OXALIPLATIN |
| 270015894 | 270019581 | 1.87 | null | Adjuvant (A) | 2019-01-25 | 2019-02-01 | Capecitabine + Oxaliplatin 21day | 02 | N | 270011823 | CAPECITABINE + OXALIPLATIN |
| 270015895 | 270019581 | null | null | null | 2018-03-08 | 2018-03-08 | Capecitabine | N | N | 270011823 | CAPECITABINE |
| 270015896 | 270008109 | 1.74 | 70 | Palliative (P) | 2013-09-24 | 2013-09-30 | Capecitabine + Oxaliplatin 21day | N | N | 270011830 | CAPECITABINE + OXALIPLATIN |
| 270015897 | 270008110 | 0 | 68 | null | 2014-07-27 | 2014-07-27 | Capecitabine | 2 | N | 270011836 | CAPECITABINE |
| 270015898 | 270008111 | 1.72 | 87 | Curative (C) | 2016-11-27 | 2016-12-11 | Brentuximab | 02 | N | 270011847 | BRENTUXIMAB |
| 270015899 | 270008112 | 1.85 | 80.2 | Palliative (P) | 2015-07-17 | 2015-08-01 | Capecitabine | 2 | N | 270011848 | CAPECITABINE |
| 270015900 | 270008114 | 1.82 | 68.3 | Curative (C) | 2015-06-02 | 2015-06-28 | Capecitabine + Oxaliplatin 21day | null | Y | 270011863 | CAPECITABINE + OXALIPLATIN |
| 270015901 | 270008115 | 1.76 | 46.4 | Palliative (P) | 2015-04-16 | 2015-04-16 | Capecitabine + Oxaliplatin 21day | 2 | N | 270011865 | CAPECITABINE + OXALIPLATIN |
| 270015902 | 270008115 | 1.61 | 93 | Curative (C) | 2016-07-22 | 2016-07-26 | Brentuximab | 02 | N | 270011865 | BRENTUXIMAB |
| 270015903 | 270008116 | null | null | Not known (9) | 2016-03-12 | 2016-04-02 | Capecitabine + Oxaliplatin 21day | N | N | 270011878 | CAPECITABINE + OXALIPLATIN |
| 270015904 | 270008116 | 1.53 | null | Disease modification (D) | 2014-11-29 | 2014-12-13 | Brentuximab | null | null | 270011878 | BRENTUXIMAB |
| 270015905 | 270008117 | 1.8 | 89.8 | Palliative (P) | 2015-02-16 | 2015-02-16 | Brentuximab | 2 | N | 270011881 | BRENTUXIMAB |
| 270015906 | 270008121 | null | 85 | Palliative (P) | null | 2014-09-26 | Brentuximab | null | null | 270011884 | BRENTUXIMAB |
| 270015907 | 270008125 | null | null | Disease modification (D) | 2017-01-22 | 2017-01-22 | Capecitabine + Oxaliplatin 21day | N | N | 270011888 | CAPECITABINE + OXALIPLATIN |
| 270015908 | 270008126 | 0 | 87.8 | null | 2015-12-05 | 2015-12-09 | Capecitabine | 02 | N | 270011897 | CAPECITABINE |
| 270015909 | 270008126 | null | null | Curative (C) | 2016-06-08 | 2016-06-09 | CAPECITABINE + OXALIPLATIN | N | N | 270011897 | CAPECITABINE + OXALIPLATIN |
| 270015910 | 270013862 | 1.8 | 87 | Disease modification (D) | 2015-08-31 | 2015-08-31 | Brentuximab Vedotin | 2 | N | 270011905 | BRENTUXIMAB |
| 270015911 | 270008128 | 1.67 | 62 | Palliative (P) | null | 2016-02-08 | Brentuximab | null | null | 270011914 | BRENTUXIMAB |
| 270015912 | 270008136 | 1.52 | 59.7 | Adjuvant (A) | 2015-12-02 | 2015-12-02 | Capecitabine | 02 | N | 270011920 | CAPECITABINE |
| 270015913 | 270013869 | null | 66 | Palliative (P) | null | 2017-12-11 | Capecitabine | N | N | 270011928 | CAPECITABINE |
| 270015914 | 270013869 | 1.67 | 61.2 | Curative (C) | 2015-04-13 | 2015-04-16 | Trial Unspecified | 02 | null | 270011928 | TRIAL |
| 270015915 | 270008140 | 1.72 | 59.5 | Curative (C) | 2014-06-15 | 2014-06-19 | Escalated BEACOPP | N | N | 270011935 | BEACOPP |
| 270015916 | 270008145 | 1.8 | 42.3 | null | null | 2013-11-24 | Escalated BEACOPP | 2 | N | 270011938 | BEACOPP |
| 270015917 | 270008147 | 0 | 64.5 | Disease modification (D) | 2017-03-09 | 2017-04-06 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270011940 | TRIAL |
| 270015918 | 270008148 | 1.69 | 68.3 | Curative (C) | 2018-03-09 | 2018-03-23 | HD EuroNet-PHL-C1 COPDAC | Y | N | 270011941 | TRIAL |
| 270015919 | 270008150 | 1.53 | 59 | Curative (C) | 2014-04-09 | 2014-04-23 | Trial Unspecified | 2 | N | 270011942 | TRIAL |
| 270015920 | 270008150 | 1.8 | 38.6 | Curative (C) | 2013-07-03 | 2013-12-18 | CETUXIMAB | 02 | null | 270011942 | CETUXIMAB |
| 270015921 | 270008152 | 1.77 | 56.4 | Curative (C) | null | 2017-09-06 | COPP + Dacarbazine | N | null | 270011948 | COPP + DACARBAZINE |
| 270015922 | 270008154 | 1.87 | 92.45 | Curative (C) | 2018-09-10 | 2018-09-13 | Escalated BEACOPP | N | N | 270011956 | BEACOPP |
| 270015923 | 270008154 | 1.74 | 66.8 | Palliative (P) | 2015-03-31 | 2015-04-01 | CETUXIMAB | 2 | N | 270011956 | CETUXIMAB |
| 270015924 | 270018171 | 1.85 | 65 | Curative (C) | 2016-11-06 | 2017-01-12 | HD EuroNet-PHL-C1 COPDAC | N | N | 270011971 | TRIAL |
| 270015925 | 270018171 | 1.8 | null | Palliative (P) | 2017-05-21 | 2017-10-01 | Cetuximab 14 day | N | null | 270011971 | CETUXIMAB |
| 270015926 | 270008156 | 1.73 | 69 | Palliative (P) | 2014-03-30 | 2014-11-19 | HD EuroNet-PHL-C1 COPDAC | 01 | N | 270011982 | TRIAL |
| 270015927 | 270013881 | 1.75 | 85 | null | 2017-05-19 | 2017-05-26 | Escalated BEACOPP | 2 | N | 270011983 | BEACOPP |
| 270015928 | 270008163 | 0 | 63.7 | Curative (C) | 2017-05-13 | 2017-05-28 | COPP + Dacarbazine | N | N | 270011984 | COPP + DACARBAZINE |
| 270015929 | 270008165 | 0 | 27.4 | Adjuvant (A) | 2015-07-31 | 2015-08-02 | COPP + Dacarbazine | 2 | N | 270011986 | COPP + DACARBAZINE |
| 270015930 | 270008167 | 0 | 86 | Curative (C) | 2017-12-22 | 2018-02-18 | COPP + Dacarbazine | N | null | 270011999 | COPP + DACARBAZINE |
| 270015931 | 270008169 | 1.42 | 88.3 | Adjuvant (A) | 2017-12-13 | 2018-02-11 | COPP + Dacarbazine | N | N | 270012005 | COPP + DACARBAZINE |
| 270015932 | 270008169 | 1.68 | null | Curative (C) | 2014-04-28 | 2014-04-29 | BEACOPP-14 | N | N | 270012005 | BEACOPP |
| 270015933 | 270013887 | 1.54 | 66.2 | Not known (9) | null | 2014-10-09 | Trial Unspecified | N | N | 270012018 | TRIAL |
| 270015934 | 270008173 | null | 79.7 | Palliative (P) | 2015-02-09 | 2015-02-13 | Cetuximab 7 day (>Cycle 2) | 02 | N | 270012020 | CETUXIMAB |